About ValiSeek

Sponsor retains sole responsibility for content.

ValiSeek Limited was formed as a Joint Venture single asset company in 2014 to progress cancer program VAL401 through early stage clinical trials to a stage attractive for out-licensing. ValiSeek is looking to initiate detailed licensing discussions prior to completion for co-development or out-licensing on a regional, global or disease specific basis to ensure a smooth continuation of their pr...

ValiSeek Limited was formed as a Joint Venture single asset company in 2014 to progress cancer program VAL401 through early stage clinical trials to a stage attractive for out-licensing. ValiSeek is looking to initiate detailed licensing discussions prior to completion for co-development or out-licensing on a regional, global or disease specific basis to ensure a smooth continuation of their project VAL401.

Contact ValiSeek

Phone Number
+44 (0)7736270615

More About ValiSeek

Therapeutic Areas
  • Oncology
Technologies
  • Drug delivery
  • Small molecules
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Private